What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment
Gazzola MG, Maclean E, Beitel M, Carmichael ID, Cammack KM, Eggert KF, Roehrich T, Madden LM, Jegede O, Zheng X, Bergman E, Barry DT. What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment. Journal Of General Internal Medicine 2022, 38: 653-660. PMID: 36163526, PMCID: PMC9971370, DOI: 10.1007/s11606-022-07813-w.Peer-Reviewed Original ResearchConceptsOpioid use disorderSubstance use disordersMethadone treatmentUse disordersOutpatient methadone treatment programMethadone treatment programsPresenting problemPreferences of patientsTerminology preferencesSubstance-dependent personsCross-sectional surveyAdult patientsMean ageUnivariate analysisMain MeasuresParticipantsPatientsTreatment programKey ResultsWeSubstance abuseSubstance useDisordersSignificant differencesTreatmentDemographic differencesAddiction counselorsCommunity based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report
Kaliamurthy S, Jegede O, Hermes G. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report. Journal Of Addictive Diseases 2022, 41: 175-180. PMID: 35377273, DOI: 10.1080/10550887.2022.2051985.Peer-Reviewed Case Reports and Technical NotesConceptsFull opioid agonistsOpioid use disorderFentanyl useOpioid agonistsUse disordersMethadone doseCommunity-based methadone maintenance programIllicit fentanyl useCharacteristics of patientsMethadone maintenance treatmentMethadone maintenance programMaintenance treatmentOutpatient clinicTime of inductionOutpatient settingCommunity clinicsBuprenorphinePatientsMore cliniciansAgonistsDisordersClinicCliniciansDoseWithdrawal